Results 221 to 230 of about 1,080,358 (387)
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch+8 more
wiley +1 more source
BglII dimorphism at the human atrial natriuretic peptide (ANP) gene locus [PDF]
P.M. Frossard+4 more
openalex +1 more source
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul+13 more
wiley +1 more source
Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis. [PDF]
Svensson MK+5 more
europepmc +1 more source
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).
Wei Song, Hao Wang, Qingyu Wu
semanticscholar +1 more source
Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié+5 more
wiley +1 more source
Acute effects of physiological increments of α-atrial natriuretic peptide in man
John C. Brown, Michael A. O'Flynn
openalex +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant+17 more
wiley +1 more source
Left Atrial Remodeling Parameters and Brain Natriuretic Peptide Levels in Nonvalvular Atrial Fibrillation. [PDF]
Amin O+3 more
europepmc +1 more source